115 related articles for article (PubMed ID: 18324356)
1. Dissociated invasively growing cancer cells with NF-kappaB/p65 positivity after radiotherapy: a new marker for worse clinical outcome in rectal cancer? Preliminary data.
Voboril R; Voborilova J; Rychterova V; Jirasek T; Dvorak J
Clin Exp Metastasis; 2008; 25(4):491-6. PubMed ID: 18324356
[TBL] [Abstract][Full Text] [Related]
2. NF-κB/p65 expression before and after treatment in rectal cancer patients undergoing neoadjuvant (chemo)radiotherapy and surgery: prognostic marker for disease progression and survival.
Voboril R; Rychterova V; Voborilova J; Kubecova M; Fanta J; Dvorak J
Neoplasma; 2016; 63(3):462-70. PubMed ID: 26952512
[TBL] [Abstract][Full Text] [Related]
3. [NF-kappaB, colorectal carcinoma and radiotherapy: results of a clinical and experimental study].
Voboril R; Weberová-Voborilová J; Rychterová V; Ambrus M; Horák L; Fanta J
Rozhl Chir; 2007 May; 86(5):268-72. PubMed ID: 17634017
[TBL] [Abstract][Full Text] [Related]
4. Nuclear factor kappa B: a marker of chemotherapy for human stage IV gastric carcinoma.
Long YM; Ye S; Rong J; Xie WR
World J Gastroenterol; 2008 Aug; 14(30):4739-44. PubMed ID: 18720533
[TBL] [Abstract][Full Text] [Related]
5. Strong cytoplasmic expression of NF-κB/p65 correlates with a good prognosis in patients with triple-negative breast cancer.
Baba M; Takahashi M; Yamashiro K; Yokoo H; Fukai M; Sato M; Hosoda M; Kamiyama T; Taketomi A; Yamashita H
Surg Today; 2016 Jul; 46(7):843-51. PubMed ID: 26494004
[TBL] [Abstract][Full Text] [Related]
6. Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients.
Montagut C; Tusquets I; Ferrer B; Corominas JM; Bellosillo B; Campas C; Suarez M; Fabregat X; Campo E; Gascon P; Serrano S; Fernandez PL; Rovira A; Albanell J
Endocr Relat Cancer; 2006 Jun; 13(2):607-16. PubMed ID: 16728586
[TBL] [Abstract][Full Text] [Related]
7. High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis.
Weichert W; Boehm M; Gekeler V; Bahra M; Langrehr J; Neuhaus P; Denkert C; Imre G; Weller C; Hofmann HP; Niesporek S; Jacob J; Dietel M; Scheidereit C; Kristiansen G
Br J Cancer; 2007 Aug; 97(4):523-30. PubMed ID: 17622249
[TBL] [Abstract][Full Text] [Related]
8. Different cellular localization of NF-κB p65 expression as an indicator of different prognoses of stage I-III gastric cancer patients.
Zhou F; Wei H; Ding A; Qiu W; Feng L; Zhou Q; Liang J; Yue L
Clin Transl Sci; 2013 Oct; 6(5):381-5. PubMed ID: 24127926
[TBL] [Abstract][Full Text] [Related]
9. Nuclear factor κ-light chain-enhancer of activated B cells is activated by radiotherapy and is prognostic for overall survival in patients with rectal cancer treated with preoperative fluorouracil-based chemoradiotheraphy.
O'Neil BH; Funkhouser WK; Calvo BF; Meyers MO; Kim HJ; Goldberg RM; Bernard SA; Caskey L; Deal AM; Wright F; Baldwin AS; Tepper JE
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):705-11. PubMed ID: 20630669
[TBL] [Abstract][Full Text] [Related]
10. Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker Network.
Grosset AA; Ouellet V; Caron C; Fragoso G; Barrès V; Delvoye N; Latour M; Aprikian A; Bergeron A; Chevalier S; Fazli L; Fleshner N; Gleave M; Karakiewicz P; Lacombe L; Lattouf JB; van der Kwast T; Trudel D; Mes-Masson AM; Saad F;
PLoS Med; 2019 Jul; 16(7):e1002847. PubMed ID: 31265453
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of nuclear factor κ B expression in patients with advanced cervical cancer undergoing radiation therapy followed by hysterectomy.
Baiocchi G; Begnami MD; Fukazawa EM; Oliveira RA; Faloppa CC; Kumagai LY; Badiglian-Filho L; Pellizzon AC; Maia MA; Jacinto AA; Soares FA; Lopes A
J Clin Pathol; 2012 Jul; 65(7):614-8. PubMed ID: 22447917
[TBL] [Abstract][Full Text] [Related]
12. Co-expression of NF-κB-p65 and phosphorylated NF-κB-p105 is associated with poor prognosis in surgically resectable non-small cell lung cancer.
Lin G; Li C; Huang C; Zhuang W; Huang Y; Xu H; Miao Q; Hu D
J Cell Mol Med; 2018 Mar; 22(3):1923-1930. PubMed ID: 29363879
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C-α (PKCα) modulates cell apoptosis by stimulating nuclear translocation of NF-kappa-B p65 in urothelial cell carcinoma of the bladder.
Zheng J; Kong C; Yang X; Cui X; Lin X; Zhang Z
BMC Cancer; 2017 Jun; 17(1):432. PubMed ID: 28629334
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of expression of nuclear factor kappa-B/p65 in non-GCB DLBCL patients.
Wang J; Zhou M; Zhang QG; Xu J; Lin T; Zhou RF; Li J; Yang YG; Chen B; Ouyang J
Oncotarget; 2017 Feb; 8(6):9708-9716. PubMed ID: 28039454
[TBL] [Abstract][Full Text] [Related]
15. Heparanase expression in gallbladder carcinoma and its correlation to prognosis.
Wu W; Pan C; Yu H; Gong H; Wang Y
J Gastroenterol Hepatol; 2008 Mar; 23(3):491-7. PubMed ID: 17524042
[TBL] [Abstract][Full Text] [Related]
16. Significance of Tissue Expression and Serum Levels of Angiopoietin-like Protein 4 in Breast Cancer Progression: Link to NF-κB /P65 Activity and Pro-Inflammatory Cytokines.
Shafik NM; Mohamed DA; Bedder AE; El-Gendy AM
Asian Pac J Cancer Prev; 2015; 16(18):8579-87. PubMed ID: 26745120
[TBL] [Abstract][Full Text] [Related]
17. Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer.
Gannon PO; Lessard L; Stevens LM; Forest V; Bégin LR; Minner S; Tennstedt P; Schlomm T; Mes-Masson AM; Saad F
Eur J Cancer; 2013 Jul; 49(10):2441-8. PubMed ID: 23541563
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression.
Shukla S; MacLennan GT; Fu P; Patel J; Marengo SR; Resnick MI; Gupta S
Neoplasia; 2004; 6(4):390-400. PubMed ID: 15256061
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-7 as a potential therapeutic target for aberrant NF-κB-driven distant metastasis of gastric cancer.
Ye T; Yang M; Huang D; Wang X; Xue B; Tian N; Xu X; Bao L; Hu H; Lv T; Huang Y
J Exp Clin Cancer Res; 2019 Feb; 38(1):55. PubMed ID: 30728051
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor-κB predicts outcome in locally advanced rectal cancer patients receiving neoadjuvant radio-chemotherapy.
Berardi R; Maccaroni E; Mandolesi A; Mantello G; Onofri A; Biscotti T; Pierantoni C; Siquini W; Marmorale C; Guerrieri M; Bearzi I; Cascinu S
Dig Liver Dis; 2012 Jul; 44(7):617-22. PubMed ID: 22440241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]